GL1X · GenesisL1 explorer

MolNFT v1 · #148196 · protein

Cathepsin L in complex with (3S,14E)-19-chloro-N-(1-cyanocyclopropyl)- 5-oxo-12,17-dioxa-4-AZATRICYCLO[16.2.2.06,11]DOCOSA-1(21),6(11),7,9, 14,18(22),19-heptaene-3-carboxamide

6EZP · Cathepsin L1: “Cathepsin L in complex with (3S,14E)-19-chloro-N-(1-cyanocyclopropyl)…”. X-ray diffraction, 1 ligand (C3E), 1 pocket (best druggability 0.32). MolNFT v1 #148196 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
6EZP
Type
protein
Length
217 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cathepsin L1
EC
3.4.22.15
UniProt
P07711
Ligands
C3E
Pockets
1 · best druggability 0.32

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACathepsin L1 (EC 3.4.22.15)protein21730% helix, 22% strandP07711

Ligands and binding sites

  • C3E · (3~{S},14~{E})-19-chloranyl-~{N}-(1-cyanocyclopropyl)-5-oxidanylidene-12,17-dioxa-4-azatricyclo[16.2.2.0^{6,11}]docosa-1(21),6(11),7,9,14,18(22),19-heptaene-3-carboxamide · ligand · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1640.320.7618C3E

Modifications

Observed in the structure: 3 disulfide, 1 covalent (disulfide, covalent ligand).

Compared structures

  • 6EZP · CATHEPSIN L IN COMPLEX WITH (3S,14E)-19-chloro-N-(1-cyanocyclopropyl)-5-oxo-12,17-dioxa-4… · the same entry in another collection · chain A against A, TM-score 1.00
  • P07711 · AlphaFold monomer V2.0 prediction for procathepsin L (P07711) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.